COVID-19 Research | NIH Common Fund

Support for COVID-19 Research

The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. The Office of Strategic Coordination (OSC), which manages the Common Fund is using these funds to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19). OSC issued immediate funding opportunities in Fiscal Year 2020 for active Common Fund researchers to conduct SARS-CoV-2 and COVID-19 research. Awards issued through these funding opportunities are listed below.

Helpful Links

Making Decisions About Your Health and How You Can Help: U.S. Department of Health and Human Services (HHS)’s Combat COVID-19 website
Funding Opportunities: COVID-19 page of information for NIH applicants and recipients of NIH funding

Future Research Funding Opportunities

In future years, OSC will use CARES Act funds allocated to the NIH Common Fund for researchers to develop new research projects starting in Fiscal Year 2021. Continue to check this page for updates on future SARS-CoV-2 and COVID-19 research funding opportunities from the NIH Common Fund.

For a list of funding opportunities from multiple NIH Institutes, Centers, and Offices — including the NIH Common Fund — please visit the COVID-19 page of information for NIH applicants and recipients of NIH funding.

Emergency Competitive Revisions for Research on SARS-COV-2 and COVID-19

In Fiscal Year 2020, the Office of Strategic Coordination (OSC), issued a Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015) to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19).

OSC issued emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative research on COVID-19 or SARS-CoV-2 in areas of research including behavioral/social science, health disparities, and novel therapeutics, that fits within the mission of an emergency response to provide critical expertise, resources or activities. A list of funded projects is available on the Common Fund Support for COVID-19 funded research section below.

Funded Research

Expand All to search section using Ctrl+F | Expand All

NOTICE OF SPECIAL INTEREST (NOSI): NOT-RM-20-015

Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-RM-20-015
PI Name	Institution Name	Title	Common Fund Program
ASHLEY, EUAN A (contact) WHEELER, MATTHEW THOMAS	STANFORD UNIVERSITY	Stanford MoTrPAC Bioinformatics Center	Molecular Transducers of Physical Activity Consortium (MoTrPAC)
BILAL, USAMA	DREXEL UNIVERSITY	The Health Consequences of Urban Scaling	NIH Director's Early Independence Award (EIA)
BRAUN, ROBERT E (contact) MURRAY, STEPHEN A WHITE, JACQUELINE K	JACKSON LABORATORY	The Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)	Knockout Mouse Phenotyping Program (KOMP2)
DEKOSKY, BRANDON JAMES	UNIVERSITY OF KANSAS LAWRENCE	Antibody Display Libraries for Precision Screening of Antibody Immune Responses to SARS CoV-2	NIH Director's Early Independence Award (EIA)
GOLUB, TODD R. (contact) SUBRAMANIAN, ARAVIND	BROAD INSTITUTE, INC.	Discovering Existing Medicines that Abrogate Cellular Responses to SARS CoV-2 Infection	Library of Integrated Network-based Cellular Signatures (LINCS)
SANJANA, NEVILLE	NEW YORK GENOME CENTER	In situ functional genomics to understand transcriptional regulation	NIH Director's New Innovator Award (NIA)
TULSKY, JAMES A. (contact) VOLANDES, ANGELO	DANA-FARBER CANCER INST	A Telehealth Advance Care Planning Intervention for COVID-19 in New York City	HCS Research Collaboratory (NIH Collaboratory)
ZHANG, HAICHONG	WORCESTER POLYTECHNIC INSTITUTE	Robotic Lung Ultrasound for Triage of COVID-19 Patients in a Resource Limited Environment	NIH Director's Early Independence Award (EIA)

2021 NIH Director's Transformative Research Emergency COVID-19 Awards (RFA-RM-20-020)

Due to the public health emergency, the Transformative Research Award and Early Independence Award issued additional funding opportunities for COVID-19-related research on the prevention of, preparation for, or response to coronavirus SARS-CoV-2 using funds provided through the CARES Act.

PI Name	Institution Name	Title
DEB, ARJUN (contact); ARUMUGASWAMI, VAITHILINGARAJA ; GRAEBER, THOMAS G; PELLEGRINI, MATTEO	UNIVERSITY OF CALIFORNIA LOS ANGELES	Metabolic and Epigenetic Reprogramming of Vital Organs in SARS-CoV-2 Induced Systemic Toxicity
MANCEBO, RICARDO	GENENDEAVOR, LLC	Development of a Handheld Rapid Air Sensing System to Monitor and Quantify SARS-CoV-2 in Aerosols in Real-Time
RAY, ANIMESH (contact); HERNANDEZ, JENIFFER BERTHA	KECK GRADUATE INST OF APPLIED LIFE SCIS	Rapid Response for Pandemics: Single Cell Sequencing and Deep Learning to Predict Antibody Sequences Against an Emerging Antigen
WEINBERGER, LEOR S (contact); RODICK, ROBERT	VXBIOSCIENCES, INC.	Autonomously Deploying, Co-Evolving SARS-CoV-2 Antiviral: A New Paradigm for Pandemic Prevention
YAKOUB, ABRAAM M (contact); LAZARTIGUES, ERIC D; TSENG, CHIEN-TE K	UNIVERSITY OF NORTH DAKOTA	SARS-CoV-2 Tropism in the Brain and Its Relationship to COVID-19 Pathogenesis